We’re delighted and honored to announce that Clara Biotech has been selected as one of the Top 10 leading-edge biotech startup companies to participate in the exclusive BioTools Innovator 2021 Accelerator! Clara is proud to be the only Midwestern company represented in the cohort.
The new program is powered by MedTech Innovator, the largest life science accelerator globally, whose goal is to support entrepreneurs in the biotechnology industry.
The three-month virtual program allows Clara Biotech access to elite mentorship from senior industry leaders, along with a customized educational curriculum. Not only will we gain a great deal of visibility throughout the program, but it will also give us a unique opportunity to meet with investors, potential partners, and stakeholders.
The BioTools Innovator program received over 160 applications from promising biotech startups worldwide, but only ten companies were selected for the BioTools Innovator 2021 Cohort. Five of the cohort companies will be selected as finalists and advance to the Grand Finals.
The BioTools Innovator Capstone Event and the Finals Competition will take place in Carlsbad, California, on October 14. A live audience vote will determine the winner who stands to win the title of the BioTools Innovator 2021 Grand Prize Winner, as well as a non-dilutive cash prize of $200,000. Register for the Livestream at https://bticapstone2021.eventbrite.com.
As part of the program, the cohort companies will create and submit a video for a mini competition. We invite you to join us on our journey, and you can follow us on LinkedIn & Twitter to stay up to date and support us!
About Clara Biotech Clara Biotech enables tomorrow’s medical breakthroughs today through exosomes. The company solves the major roadblock preventing exosome solutions from reaching patients — purification of exosomes from biofluids. Clara Biotech’s solution enables breakthroughs in diagnostics and therapeutic pathways for a wide variety of conditions, including cancer, Alzheimer’s Disease, multiple sclerosis, ischemic stroke, and more. For more information, visit clarabio.tech.